Failures to further developing orphan medicinal products after designation granted in Europe: an analysis of marketing authorisation failures and abandoned drugs

OBJECTIVES: The research and development process in the field of rare diseases is characterised by many well-known difficulties, and a large percentage of orphan medicinal products do not reach the marketing approval. This work aims at identifying orphan medicinal products that failed the developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Giannuzzi, Viviana, Landi, Annalisa, Bosone, Enrico, Giannuzzi, Floriana, Nicotri, Stefano, Torrent-Farnell, Josep, Bonifazi, Fedele, Felisi, Mariagrazia, Bonifazi, Donato, Ceci, Adriana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595174/
https://www.ncbi.nlm.nih.gov/pubmed/28893754
http://dx.doi.org/10.1136/bmjopen-2017-017358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595174/
https://www.ncbi.nlm.nih.gov/pubmed/28893754
http://dx.doi.org/10.1136/bmjopen-2017-017358

Ejemplares similares